SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-014574
Filing Date
2021-11-04
Accepted
2021-11-04 16:03:25
Documents
81
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q coll-20210930x10q.htm   iXBRL 10-Q 2011475
2 EX-31.1 coll-20210930xex31d1.htm EX-31.1 13410
3 EX-31.2 coll-20210930xex31d2.htm EX-31.2 13434
4 EX-32.1 coll-20210930xex32d1.htm EX-32.1 7695
5 EX-32.2 coll-20210930xex32d2.htm EX-32.2 7533
6 GRAPHIC coll-20210930x10q001.jpg GRAPHIC 10048
  Complete submission text file 0001558370-21-014574.txt   9472564

Data Files

Seq Description Document Type Size
7 EX-101.SCH coll-20210930.xsd EX-101.SCH 61997
8 EX-101.CAL coll-20210930_cal.xml EX-101.CAL 69977
9 EX-101.DEF coll-20210930_def.xml EX-101.DEF 237708
10 EX-101.LAB coll-20210930_lab.xml EX-101.LAB 548704
11 EX-101.PRE coll-20210930_pre.xml EX-101.PRE 426922
12 EXTRACTED XBRL INSTANCE DOCUMENT coll-20210930x10q_htm.xml XML 2042761
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37372 | Film No.: 211379840
SIC: 2834 Pharmaceutical Preparations